News
A retrospective analysis of US medical records of people aged 65-95 years finds those with psoriasis on systemic therapies ...
Certain biologic therapies, such as ustekinumab, significantly effect hematological and lipid parameters in patients with psoriasis.
The majority of Enbrel's sales are in rheumatology, as the drug is approved in indications including rheumatoid arthritis, plaque psoriasis ... launch its biosimilar Remicade until October ...
May 27, 2025 — Researchers have found that central body fat, especially around the abdomen, is more strongly linked to psoriasis risk than total body fat, particularly in women. This link ...
Discover how simple lifestyle changes — like exercise, diet, and better sleep — can help reduce symptoms and improve quality ...
If you have psoriasis, you may feel like this autoimmune disease is plenty to cope with all on its own. But unfortunately there are a number of other health issues linked to the condition.
Psoriasis attacks healthy cells, causing inflammation that leads to plaques and other skin changes. Some of the same underlying triggers that drive psoriasis may also pose problems for your heart ...
BMS has previously said it reckons Sotyktu could become a $4 billion seller at its peak, fuelled by head-to-head studies showing it was more effective at treating moderate-to-severe psoriasis than ...
However, they are sometimes signs of a condition requiring treatment, such as psoriasis, contact dermatitis, or head lice. Treatment options for scalp sores or scabs depend on the cause but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results